Logo image of ME9.DE

MEDIOBANCA SPA (ME9.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ME9 - IT0000062957 - Common Stock

17.365 EUR
-0.05 (-0.26%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ME9. ME9 was compared to 114 industry peers in the Banks industry. ME9 has a medium profitability rating, but doesn't score so well on its financial health evaluation. ME9 has a decent growth rate and is not valued too expensively. Finally ME9 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ME9 had positive earnings in the past year.
In the past year ME9 has reported a negative cash flow from operations.
Each year in the past 5 years ME9 has been profitable.
In multiple years ME9 reported negative operating cash flow during the last 5 years.
ME9.DE Yearly Net Income VS EBIT VS OCF VS FCFME9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

ME9 has a Return On Assets of 1.92%. This is amongst the best in the industry. ME9 outperforms 92.98% of its industry peers.
With an excellent Return On Equity value of 17.82%, ME9 belongs to the best of the industry, outperforming 88.60% of the companies in the same industry.
Industry RankSector Rank
ROA 1.92%
ROE 17.82%
ROIC N/A
ROA(3y)1.23%
ROA(5y)1.13%
ROE(3y)10.79%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ME9.DE Yearly ROA, ROE, ROICME9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

ME9 has a Profit Margin of 33.78%. This is amongst the best in the industry. ME9 outperforms 84.21% of its industry peers.
ME9's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ME9 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 33.78%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.47%
PM growth 5Y7.62%
GM growth 3YN/A
GM growth 5YN/A
ME9.DE Yearly Profit, Operating, Gross MarginsME9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1

2. Health

2.1 Basic Checks

ME9 does not have a ROIC to compare to the WACC, probably because it is not profitable.
ME9 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ME9 has less shares outstanding
Compared to 1 year ago, ME9 has a worse debt to assets ratio.
ME9.DE Yearly Shares OutstandingME9.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
ME9.DE Yearly Total Debt VS Total AssetsME9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

ME9 has a Debt/Equity ratio of 4.37. This is a high value indicating a heavy dependency on external financing.
ME9's Debt to Equity ratio of 4.37 is on the low side compared to the rest of the industry. ME9 is outperformed by 85.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.76%
ME9.DE Yearly LT Debt VS Equity VS FCFME9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ME9.DE Yearly Current Assets VS Current LiabilitesME9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

ME9 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.38%, which is quite good.
ME9 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.34% yearly.
ME9 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.63%.
The Revenue has been growing slightly by 4.61% on average over the past years.
EPS 1Y (TTM)15.38%
EPS 3Y4.6%
EPS 5Y4.34%
EPS Q2Q%4.36%
Revenue 1Y (TTM)5.63%
Revenue growth 3Y4.97%
Revenue growth 5Y4.61%
Sales Q2Q%-52.5%

3.2 Future

The Earnings Per Share is expected to grow by 12.70% on average over the next years. This is quite good.
Based on estimates for the next years, ME9 will show a small growth in Revenue. The Revenue will grow by 7.93% on average per year.
EPS Next Y19.1%
EPS Next 2Y21.37%
EPS Next 3Y17.06%
EPS Next 5Y12.7%
Revenue Next Year15.58%
Revenue Next 2Y13.49%
Revenue Next 3Y10.4%
Revenue Next 5Y7.93%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ME9.DE Yearly Revenue VS EstimatesME9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ME9.DE Yearly EPS VS EstimatesME9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.54, which indicates a correct valuation of ME9.
Based on the Price/Earnings ratio, ME9 is valued more expensive than 85.09% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. ME9 is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.23 indicates a reasonable valuation of ME9.
ME9's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.04. ME9 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.54
Fwd PE 11.23
ME9.DE Price Earnings VS Forward Price EarningsME9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ME9.DE Per share dataME9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ME9's earnings are expected to grow with 17.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.87
PEG (5Y)3.81
EPS Next 2Y21.37%
EPS Next 3Y17.06%

7

5. Dividend

5.1 Amount

ME9 has a Yearly Dividend Yield of 6.63%, which is a nice return.
ME9's Dividend Yield is rather good when compared to the industry average which is at 4.12. ME9 pays more dividend than 85.96% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.88, ME9 pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.63%

5.2 History

On average, the dividend of ME9 grows each year by 19.69%, which is quite nice.
Dividend Growth(5Y)19.69%
Div Incr YearsN/A
Div Non Decr YearsN/A
ME9.DE Yearly Dividends per shareME9.DE Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

ME9 pays out 47.29% of its income as dividend. This is a bit on the high side, but may be sustainable.
ME9's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP47.29%
EPS Next 2Y21.37%
EPS Next 3Y17.06%
ME9.DE Yearly Income VS Free CF VS DividendME9.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B
ME9.DE Dividend Payout.ME9.DE Dividend Payout, showing the Payout Ratio.ME9.DE Dividend Payout.PayoutRetained Earnings

MEDIOBANCA SPA

FRA:ME9 (12/23/2025, 7:00:00 PM)

17.365

-0.05 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-10 2026-02-10
Inst Owners93.42%
Inst Owner ChangeN/A
Ins Owners7.85%
Ins Owner ChangeN/A
Market Cap14.12B
Revenue(TTM)5.90B
Net Income(TTM)1.99B
Analysts75
Price Target19.25 (10.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.63%
Yearly Dividend1.15
Dividend Growth(5Y)19.69%
DP47.29%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.44%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)0.75%
Revenue beat(4)2
Avg Revenue beat(4)26.1%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)109.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.85%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.54
Fwd PE 11.23
P/S 2.39
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.4
EV/EBITDA N/A
EPS(TTM)1.05
EY6.05%
EPS(NY)1.55
Fwd EY8.91%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS7.26
BVpS13.75
TBVpS12.42
PEG (NY)0.87
PEG (5Y)3.81
Graham Number18.03
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 17.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 33.78%
GM N/A
FCFM N/A
ROA(3y)1.23%
ROA(5y)1.13%
ROE(3y)10.79%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y3.47%
PM growth 5Y7.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC5.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)2.73%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y4.6%
EPS 5Y4.34%
EPS Q2Q%4.36%
EPS Next Y19.1%
EPS Next 2Y21.37%
EPS Next 3Y17.06%
EPS Next 5Y12.7%
Revenue 1Y (TTM)5.63%
Revenue growth 3Y4.97%
Revenue growth 5Y4.61%
Sales Q2Q%-52.5%
Revenue Next Year15.58%
Revenue Next 2Y13.49%
Revenue Next 3Y10.4%
Revenue Next 5Y7.93%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-483.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-373.71%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIOBANCA SPA / ME9.DE FAQ

What is the fundamental rating for ME9 stock?

ChartMill assigns a fundamental rating of 4 / 10 to ME9.DE.


What is the valuation status of MEDIOBANCA SPA (ME9.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to MEDIOBANCA SPA (ME9.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for MEDIOBANCA SPA?

MEDIOBANCA SPA (ME9.DE) has a profitability rating of 4 / 10.


How financially healthy is MEDIOBANCA SPA?

The financial health rating of MEDIOBANCA SPA (ME9.DE) is 1 / 10.


What is the earnings growth outlook for MEDIOBANCA SPA?

The Earnings per Share (EPS) of MEDIOBANCA SPA (ME9.DE) is expected to grow by 19.1% in the next year.